ZA947052B - Intravenously administrable aqueous solution - Google Patents
Intravenously administrable aqueous solutionInfo
- Publication number
- ZA947052B ZA947052B ZA947052A ZA947052A ZA947052B ZA 947052 B ZA947052 B ZA 947052B ZA 947052 A ZA947052 A ZA 947052A ZA 947052 A ZA947052 A ZA 947052A ZA 947052 B ZA947052 B ZA 947052B
- Authority
- ZA
- South Africa
- Prior art keywords
- aqueous solution
- intravenously administrable
- administrable aqueous
- intravenously
- sulfametrole
- Prior art date
Links
- 239000007864 aqueous solution Substances 0.000 title abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract 1
- 235000011090 malic acid Nutrition 0.000 abstract 1
- 239000001630 malic acid Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960001153 serine Drugs 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- IZOYMGQQVNAMHS-UHFFFAOYSA-N sulfametrole Chemical compound COC1=NSN=C1NS(=O)(=O)C1=CC=C(N)C=C1 IZOYMGQQVNAMHS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001969 sulfametrole Drugs 0.000 abstract 1
- 229960002898 threonine Drugs 0.000 abstract 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 abstract 1
- 229960001082 trimethoprim Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4331147A DE4331147A1 (de) | 1993-09-14 | 1993-09-14 | Intravenös verabreichbare, wäßrige Lösung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA947052B true ZA947052B (en) | 1995-04-26 |
Family
ID=6497666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA947052A ZA947052B (en) | 1993-09-14 | 1994-09-13 | Intravenously administrable aqueous solution |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5554618A (xx) |
| EP (1) | EP0653210B1 (xx) |
| JP (1) | JPH07149653A (xx) |
| AT (1) | ATE150309T1 (xx) |
| CA (1) | CA2132034A1 (xx) |
| DE (2) | DE4331147A1 (xx) |
| DK (1) | DK0653210T3 (xx) |
| ES (1) | ES2103526T3 (xx) |
| FI (1) | FI944219A (xx) |
| GR (1) | GR3023841T3 (xx) |
| HU (1) | HUT70053A (xx) |
| IL (1) | IL110945A0 (xx) |
| ZA (1) | ZA947052B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1478339T1 (sl) | 2002-02-22 | 2008-10-31 | Schering Corp | Farmacevtske formulacije antineoplastičnih sredstev, zlasti temozolomida, postopki za pripravo in uporabo le-teh |
| EP1938798A1 (en) * | 2002-02-22 | 2008-07-02 | Schering Corporation | Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| UA92423C2 (xx) * | 2009-07-24 | 2010-10-25 | Анатолій Альбертович Кузьмін | Антибактеріальна композиція[антибактериальная композиция |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT270869B (de) * | 1966-05-09 | 1969-05-12 | Hoffmann La Roche & Co Aktiege | Verfahren zur Herstellung von Sulfonamid-Potentiator-Lösungen |
| GB1469521A (en) | 1973-01-05 | 1977-04-06 | Wellcome Found | Antimicrobial preparations |
| DE2731013C2 (de) * | 1977-07-08 | 1982-07-15 | Lentia Gmbh | Verfahren zur Herstellung einer wäßrigen Infusionslösung |
| CH647412A5 (de) * | 1980-03-25 | 1985-01-31 | Hoffmann La Roche | Pharmazeutische praeparate. |
| US4732915A (en) * | 1983-11-02 | 1988-03-22 | Alza Corporation | Process for increasing solubility of drug |
| US5008255A (en) * | 1989-01-12 | 1991-04-16 | Alcon Laboratories, Inc. | Method for enhancing solubility of trimethoprim with sodium sulfacetamide, and synergistic pharmaceutical compositions derived therefrom |
-
1993
- 1993-09-14 DE DE4331147A patent/DE4331147A1/de not_active Withdrawn
-
1994
- 1994-09-05 DK DK94113875.2T patent/DK0653210T3/da active
- 1994-09-05 ES ES94113875T patent/ES2103526T3/es not_active Expired - Lifetime
- 1994-09-05 DE DE59402136T patent/DE59402136D1/de not_active Expired - Fee Related
- 1994-09-05 EP EP94113875A patent/EP0653210B1/de not_active Expired - Lifetime
- 1994-09-05 AT AT94113875T patent/ATE150309T1/de active
- 1994-09-13 ZA ZA947052A patent/ZA947052B/xx unknown
- 1994-09-13 JP JP6219012A patent/JPH07149653A/ja not_active Withdrawn
- 1994-09-13 FI FI944219A patent/FI944219A/fi not_active Application Discontinuation
- 1994-09-13 IL IL11094594A patent/IL110945A0/xx unknown
- 1994-09-13 HU HU9402627A patent/HUT70053A/hu unknown
- 1994-09-14 CA CA002132034A patent/CA2132034A1/en not_active Abandoned
- 1994-09-14 US US08/305,605 patent/US5554618A/en not_active Expired - Fee Related
-
1997
- 1997-06-19 GR GR970401479T patent/GR3023841T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0653210B1 (de) | 1997-03-19 |
| ATE150309T1 (de) | 1997-04-15 |
| HU9402627D0 (en) | 1994-11-28 |
| ES2103526T3 (es) | 1997-09-16 |
| HUT70053A (en) | 1995-09-28 |
| DE4331147A1 (de) | 1995-03-16 |
| FI944219A0 (fi) | 1994-09-13 |
| CA2132034A1 (en) | 1995-03-15 |
| US5554618A (en) | 1996-09-10 |
| IL110945A0 (en) | 1994-11-28 |
| DK0653210T3 (da) | 1997-10-06 |
| DE59402136D1 (de) | 1997-04-24 |
| JPH07149653A (ja) | 1995-06-13 |
| EP0653210A1 (de) | 1995-05-17 |
| GR3023841T3 (en) | 1997-09-30 |
| FI944219A (fi) | 1995-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9500260D0 (en) | Controlled release morphine preparation | |
| CA2140923A1 (en) | Lowering the pH of Textile Processing Solution with an Acid/Base Salt as a pH Adjusting Agent | |
| ES2119812T3 (es) | Catalasa, su produccion y uso. | |
| CA2076410A1 (en) | Sporicidal disinfectant compositions, production and use thereof | |
| TW338068B (en) | Defined medium OMPC fermentation process | |
| CA2020858A1 (en) | Water treatment agent and water treatment method for boiler | |
| UA6153A1 (uk) | Гербіцідна композіція | |
| ZA985023B (en) | A process for the preparation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid and the derivatives thereof | |
| EP0807434A4 (en) | ANTI-INFLAMMATORY EYE DROPS | |
| ZA947052B (en) | Intravenously administrable aqueous solution | |
| MX9703339A (es) | Solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina. | |
| ZA983483B (en) | A process for the preparation of 1,4,7,10-tetraazacyclodo-decane | |
| TW360628B (en) | Process for the preparation of methylamines | |
| ES2070806A1 (es) | Jarabe que contiene n-acetil-cisteina. | |
| AU574836B2 (en) | N-(4(1h)-pyridinylidene) alkylamines | |
| BG102347A (en) | New carboxylic acid derivatives, method for their preparation and application | |
| ES8800345A1 (es) | Procedimiento para la obtencion de sarcosinoxidasa | |
| UA39178C2 (uk) | Спосіб мінімізації деградації активованого протеїну с (варіанти), фармацевтична композиція та водний розчин активованого протеїну с | |
| HU900804D0 (en) | Process for preparing pentamydine solutions | |
| GR3036481T3 (en) | Medicament containing delta-aminolevulinic acid | |
| UA30209A (uk) | Спосіб застосування тетрадиметилсульфоксидгексаметилентетрамінбісдихлориду кобальту (іі) для підвищення врожайності сільськогосподарських культур | |
| JPS57132882A (en) | Preparation of l-alanine and d-aspartic acid | |
| GR970100090A (el) | Διαδικασια παραγωγης 1,2-διμεθυλ-3-υδροξυπυριδ-4-ονης | |
| GR960100116A (el) | Μεθοδος παρασκευης 1-κυκλοπροπυλο-6-φλουορο-1,4-διυδρο-7-[(1s,4s)-5-μεθυλο-2,5-διαζαβικυκλο[2.2.1]-επτ-2-υλο] -4-οξο-3-κουινολινοκαρβοξυλικο οξυ και αλατα αυτων. | |
| ES8507140A1 (es) | Procedimiento para la preparacion del citrato de la (-) vinburnina |